Back

Impact of calculated LDL-c on residual cardiovascular risk assessment

23 April 2026 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Lipid-centred risk assessment Lipids EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Mrs Biljana Koleva

Skopje (North Macedonia)

4 More presentations in this session

Presentation thumbnail
Pericoronary adipose tissue attenuation and effective atomic number as novel imaging biomarkers for severe coronary artery stenosis
Associate Professor M. Marketou (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Prevalence and characteristics of patients with extremely high 400 LDL-C levels in a large healthcare system
Doctor J. Rana (Oakland, US)
Abstract Slides
Presentation thumbnail
Extension of coronary artery disease and resistance to lipid-lowering treatment. Value of Lp(a)
Doctor L. Tojal Sierra (Vitoria-Gasteiz, ES)
Abstract Slides
Presentation thumbnail
When apolipoprotein B speaks: early clues to coronary disease burden
Doctor I. Aguiar Ricardo (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
Lipid-centred risk assessment

The Event

Event poster

ESC Preventive Cardiology 2026

23 April 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Risk factors control, remnant cholesterol, recurrent events and risk in patients with coronary heart disease. Our experiences
thumbnail
Congress Presentation
Remnant cholesterol and its role in patients with coronary atherosclerosis evaluated by coronary CT
thumbnail
Congress Presentation
LDL-C reduction and residual cardiovascular risk in heterozygous familial hypercholesterolemia: a matched cohort study in South Wales

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources